What has changed?

• Question 5.9 is new. It regulates the distribution of medicinal products without safety features in Italy and Greece during the transitional period.
• Questions 1.6, 1.28, 7.15, 8.9 have been revised. They deal, e. g., with safety features for medicinal products used in research and development or parallel imports. Question 8.9 clarifies the remains on the market of medicinal products without safety features.

The Q&A is continuously updated and supplemented with questions that arise during the implementation of the legal requirements in practice.

Source:

EC: Q&A